1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. MALARIA DIAGNOSTICS MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Rapid Diagnostic Tests (RDTs)
5.3. Microscopy
5.4. Molecular Diagnostics
5.5. Serology-based Tests
5.6. Other Technologies
6. MALARIA DIAGNOSTICS MARKET BY END-USERS
6.1. Introduction
6.2. Hospitals and Clinics
6.3. Diagnostic Laboratories
6.4. Research Institutes
6.5. NGOs and Government Health Programs
7. MALARIA DIAGNOSTICS MARKET BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Direct Tenders & Institutional Sales
7.3. Retail and Private
8. MALARIA DIAGNOSTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Technology
8.2.2. By End-Users
8.2.3. By Distribution Channel
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Technology
8.3.2. By End-Users
8.3.3. By Distribution Channel
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Technology
8.4.2. By End-Users
8.4.3. By Distribution Channel
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Technology
8.5.2. By End-Users
8.5.3. By Distribution Channel
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Technology
8.6.2. By End-Users
8.6.3. By Distribution Channel
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. South Korea
8.6.4.4. India
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Motic (Xiamen) Electric Group Co., Ltd.
10.2. Sight Diagnostics Ltd.
10.3. bioMérieux SA
10.4. Intellectual Ventures Laboratory, LLC
10.5. Access Bio. Inc.
10.6. Sysmex Europe GmbH
10.7. Abbott Laboratories
10.8. Meridian Bioscience, Inc.
10.9. QuantuMDx Group Ltd.
10.10. Hemex Health, Inc.
10.11. F. Hoffmann-La Roche Ltd.
10.12. Bio-Rad Laboratories, Inc.
10.13. Thermo Fisher Scientific Inc.
10.14. Premier Medical Corporation Pvt. Ltd.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key Benefits for the Stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES